NAMs Qualification Pathways

Navigate the complex process of qualifying New Approach Methodologies for regulatory acceptance across FDA, EMA, OECD, and global agencies.

Innovative Science and Technology Approaches for New Drugs pilot program for formal NAMs qualification with defined Context of Use.

Scientific Advice Working Party process for obtaining qualification opinions on novel methodologies valid across 27 EU member states.

International validation process for acceptance into OECD Test Guidelines program, enabling global regulatory acceptance.

International Cooperation on Alternative Test Methods harmonizing validation across NICEATM, ECVAM, JaCVAM, and KoCVAM.

Strategic early engagement with regulatory agencies before formal NAMs submissions to align on strategy and requirements.

Pragmatic pathway for NAMs acceptance in specific regulatory contexts without formal qualification when data supports use.

You need formal FDA qualification for repeated use across multiple programs → ISTAND Program

You need EU-wide acceptance with published qualification opinion → EMA SAWP

You want global standard acceptance for chemical safety testing → OECD Validation

You need NAMs for a specific program and have strong supporting data → Case-by-Case

You're uncertain about strategy or want early agency feedback → Pre-Submission Meeting

Pathway Comparison

Compare qualification pathways to select the best approach for your NAMs

Pathway	Agency	Timeline	Scope	Best For
ISTAND	FDA	12-24 months	US submissions	Drug development tools
EMA SAWP	EMA	6-18 months	EU (27 states)	Novel methodologies
OECD	OECD	3-5 years	Global (38 countries)	Chemical safety
ICATM	Multi-agency	2-4 years	International	Harmonized validation
Case-by-Case	Any	Submission-dependent	Program-specific	Single program use